CDK9 and B-cell chronic lymphocytic leukemia: Once again, treatment of the primary CLL cells for 4 h with 0.1 μM of CDKI-73 inhibited pS2 and T186 phosphorylations of RNAP II and CDK9, respectively, as well as depleted MCL-1 expression.